As all we know, gastric cancer (GC) is a highly aggressive disease. Recently, circular RNA (circRNA) was found to play a vital role in regulation of GC. Some circRNAs could regulate messenger RNA (mRNA) expression by functioning as a microRNA (miRNA) sponge. Nevertheless, the circRNA-miRNA-mRNA regulatory network involved GC rarely has been explored and researched.
Background
Gastric cancer (GC) is a disease with very high morbidity and mortality worldwide; it was responsible for over 1 000 000 new cases and 783 000 deaths in 2018, which makes it the fifth most frequently diagnosed cancer and the third leading cause of cancer death [1] . Although there has been significant progress in personalizing treatment for GC, it is still a clinically challenging disease characterized by a lack of effective treatment options and scarcely reliable molecular tools to predict patient outcomes. Compared with other cancer types, the clinical management of GC has not yet achieved the expected benefits from the era of personalized medicine [2] . Almost one third of patients experience recurrence and distant metastasis after undergoing GC surgery [3] . Therefore, the detection of molecular markers for early diagnosis, prognosis, and therapeutic targets of GC has become very urgent.
Most of the human genome is transcribed into non-proteincoding RNA, while protein-coding genome is less than 2% [4] . Circular RNA (circRNA), as one of noncoding RNAs, are derived from the precursor messenger RNA (mRNA) of RNA transcriptase II, consisting of continuous covalently closed loop without the 5'-cap structure and the 3'-poly A tail. Due to this structure, circRNAs are not easily degraded by exonuclease RNase R [5] . In particular, circRNAs are reported to play crucial roles in cancer occurrence, metastasis, and therapy resistance owning to its abundant biological effect on tumor cells including proliferation, apoptosis, and invasion [6] . CircRNAs function primarily as transcriptional and post-transcriptional regulators through various functional mechanisms, such as RNA binding protein (RBP) sponges and protein scaffolds [7] , translate proteins [8] , RNAP II elongation [9] , RNA-RNA interactions [10] , and RNA maturation [11] . At present, circRNAs function mainly by adsorbing microRNAs (miRNAs) as miRNA response elements (MRE) based on competing endogenous RNA (ceRNA) hypothesis in GC [12, 13] . For instance, augmented expression of circNF1 obviously promotes cell proliferation by sponging miR-16 in GC [14] . Another study reported that has_circ_0001461 (termed circFAT1) low expression inhibited GC cell line proliferation by regulating the miR-548g/RUNX1 axis in the cytoplasm and targeting YBX1 in the nucleus, meanwhile, it was correlated with overall survival (OS) of GC patients [15] . In addition, circRNA circPDSS1 has been shown to promote GC progression by sponging miR-186-5p to modulate NEK2 [16] .
Although several circRNAs have been identified as participating in the pathogenesis of GC, it is still necessary to conduct a circRNA-miRNA-mRNA regulatory network in GC, to help to advance our understanding of the molecular mechanism of GC. In the present study, we constructed a regulatory network consisting of 3 circRNAs, 22 miRNAs, and 128 mRNAs through multiple sets of the Gene Expression Omnibus (GEO) database and some online prediction websites, and analyzed the miRNAs and mRNAs in the network using The Cancer Genome Atlas (TCGA) database, the Gene Ontology (GO) analysis, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and the protein-protein interaction (PPI) network to indirectly understand the potential mechanism of circRNAs in the occurrence and development of GC
Material and Methods

Data collection
The microarray data used in the current study were acquired from the GEO database (http://www.ncbi.nlm.nih.gov/gds/). The circRNAs expression data were obtained from GSE78092 (3 pairs of primary GC tissue and normal gastric mucosa) and GSE89143 (3 pairs of GC tissue and matched paracancerous tissue). The miRNA and mRNA expression data were respectively derived from GSE93415 (20 pairs of gastric tumor and adjacent healthy gastric mucosa) and GSE54129 (111 tumor samples and 21 normal gastric mucosa). GC level 3 miRNAsequencing data and clinical information were downloaded from TCGA database (https://cancergenome.nih.gov/) on January 07, 2019. A total of 491 samples were included in this study, containing 446 GC samples and 45 matched normal samples. The detailed clinical information included sex, age at diagnosis, grade, T stage, N stage, M stage, and clinical stage, which is shown in Supplementary Table 1 .
Differential expression analysis of circRNAs, miRNAs, and mRNAs
The downloaded platform file(s) and series of matrix file(s) were converted through using the R language software and annotation package. The ID of the corresponding probe name was converted into an international standard name (circRNA symbol). The analysis of differentially expressed RNAs was performed using the limma package based on the Bioconductor package. The criteria for selection of differentially expressed circRNAs (DEcircRNAs) were P-value <0.05 and |log2FC| >1. Differentially expressed miRNAs (DEmiRNAs) were identified by using GEO2R in dataset GSE93415, as the |log2FC| of most miRNAs is less than 1, we set the criterion that FDR values <0.05 and |log2FC| >0.5 were considered significantly. Differentially expressed mRNAs (DEmRNAs) were also identified by using GEO2R in dataset GSE54129, with the criterion that FDR values <0.05 and |log2FC| >1 were considered significantly. In addition, miRNA-sequencing data derived from TCGA were processed with edgeR [17] , a Bioconductor package based on the R language, to screen differentially expressed miRNAs (TDEmiRNAs) between GC tissue and adjacent normal tissue. Differentially expressed miRNAs with FDR values <0.05 and |log2FC| >1 were considered significantly.
Construction of the circRNA-miRNA-mRNA regulatory network
According to the results of the differential expression analysis, we first get the intersection of DEcircRNAs between GSE78092 and GSE89143, called IDEcircRNAs.Targeting miRNAs of IDEcircRNAs were predicted via Cancer-Specific CircRNA Database (CSCD) http://gb.whu.edu.cn/CSCD/ (we called it CPmiRNAs), then we took the intersection of it and DEmiRNAs, which we called ICPDEmiRNAs. Furthermore, we used Perl language to predict respectively their target genes according to downloaded miRNA databases on the 3 target gene prediction website including miRTarBase (http://mirtarbase.mbc.nctu. edu.tw/), targetScan (http://www.targetscan.org) and miRDB (http://www.mirdb.org/). Not all target genes were included, the miRNA target genes that could be found in all 3 databases were used as the final target genes, which were named TmRNA. We took the intersection of it and the DEmRNAs in the same way, and got the final functional genes, which were denominated FmRNAs, therefore, through IDEcircRNAs, ICPDEmiRNAs, and FmRNAs, we constructed the circRNA-miRNA-mRNA regulatory network using Cytoscape.
Functional enrichment analysis
We firstly converted the gene symbol of FmRNAs in the network into entrezIDs, meanwhile, installing R language packages including "colorspace", "stringi", "DOSE", "clusterProfiler", and "pathview". Furthermore, we obtained the outcomes of the GO analysis and the KEGG pathway through R studio and R scripting language, however, not all results were included. We set a criterion that the P value of the GO analysis was less than 0.05, besides the P value and q value of the KEGG analysis were both less than 0.05, and the network diagram of the KEGG pathway containing mRNA was constructed by Cytoscape.
The analysis of miRNAs and mRNA in the network
We compared ICPDEmiRNAs and TDEmiRNAs by Venn diagram to find the sharing expressed miRNAs, whose expression in tumor tissues and normal tissues was plotted by GraphPad Prism 7, then we analyzed the clinical relevance via SPSS21.0. The hub genes of FmRNAs were screened by PPI and cytoHubba plugin. The medium confidence in the network was 0.400. In addition, their expression, survival prognosis and correlation with clinical stage were identified in GEPIA.
Statistical analysis
Statistical analysis was performed using SPSS 21.0 (Chicago, IL, USA). Significant differential expression levels of circRNAs were analyzed by R language limma packages and FDR filtering was used for comparative analysis. The P-value <0.05 and absolute fold change ³2.0 were considered statistically significant. The correlation between miRNA expression and clinical characteristics was tested by chi-square test.
Results
Identification of DEcircRNA, DEmiRNAs, DEmRNAs
The integrated analysis of GSE78092 and GSE89143 dataset respectively identified 112 and 54 differentially expressed circRNAs (DEcircRNAs) by R language limma packages, the former included 23 upregulated and 89 downregulated circRNAs, the latter had 8 and 54 ( Figure 1 ).Then, we took the intersection of DEcircRNAs of the 2 datasets, the outcome showed that they didn't have common upregulated circRNAs, while having 3 sharing downregulated circRNAs (IDEcircRNAs) (Figure 2A ), which were known as hsa_circ_004173, hsa_circ_0009076, hsa_circ_0028190 ( Figure 2B-2D ). Besides, we also used GEO2R online analysis on GSE93415 to obtain differentially expressed miRNAs. A total of 344 differentially expressed miRNAs were obtained, 149 of which were downregulated and 195 of which were upregulated ( Supplementary Table 2 ). Similarly, we also did the same analysis on GSE54129, and found 3916 differentially expressed mRNAs, including 1896 upregulated mRNAs and 2020 downregulated mRNAs (Supplementary Table 3 ).
Searching for the relationship among circRNA, miRNA, and mRNA
The results of predicted targeting miRNAs on 3 circRNAs shown that hsa_circ_0009076 had 48 targeting miRNAs, hsa_circ_0028190 had 69, and hsa_circ_0041732 had 108. A total of 202 miRNAs were obtained after the removal of the repeatedly targeted miRNAs (Supplementary Table 4 ). We got 22 common miRNAs (ICPDEmiRNAs) (Supplementary Figure 1A ) by taking the intersection of 202 targeting miRNAs and the precious 344 DEmiRNAs. In terms of target gene prediction, we obtained 431 target genes (TmRNAs) of 22 miRNAs (Supplementary Table 5 ). Finally, we obtained 128 common mRNAs (FmRNAs) (Supplementary Figure 1B) by intersecting the TmRNAs with the previously obtained 3916 DEmRNAs.
Constructing of circRNA-miRNA-mRNA network.
From the previous data analysis, we got IDEcircRNAs including 3 downregulated circRNAs, 22 ICRDEmiRNAs including 13 8779 upregulated, 9 downregulated, 128 FmRNAs including 69 upregulated and 59 downregulated. Then, we use Cytoscape Version3.6.1 soft to describe their relationships in the network, 3 circRNAs had 24 targeted relationship with 22 miRNAs, 22 miRNAs have 139 targeted relationship with 128 DEmiRNA-mRNAs ( Figure 3 ).
The correlation of clinical characteristics and miRNAs
In order to further explore clinical correlation of miRNAs in the network, we first got 242 TDEmiRNAs including 178 upregulated and 69 downregulated (Supplementary Table 6 , Supplementary Figure 2 ) in the stomach TCGA database. Compared with the precious 22 ICPDE miRNAs, we got the 3 same expression mode miRNAs. The situation of 3 miRNAs was displayed in Figure 4 , then we analyzed their correlation with 
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the clinical characteristics. The results were shown in Table 1 : hsa-mir-182 was associated with T stage (P=0.006) and N stage (P=0.013), hsa-mir-96 was associated with age (P=0.025),
T stage (P=0.003) and N stage (P=0.042), and hsa-mir-195 was associated with N stage (P=0.029). LAB/IN VITRO RESEARCH circRNA, including GO enrichment analysis and KEGG pathway analysis. In the GO analysis, including biological process, cellular component and molecular function, we obtained 49 results, which were shown in Table2. In KEGG pathway analysis, we got 24 results, which were shown in Table 3 .The dotplot showed the results of the top 20 GO analysis results with P value from small to large, as well as the results of KEGG pathway, most of which were related to the density of tumor ( Figure 5A, 5B ).
In addition, we also constructed the network diagram of the relationship between KEGG pathway and each mRNA ( Figure 5C ).
In the tumor-associated signaling pathway, KEGG analysis showed that the PI3K-Akt signaling pathway contained the most genes (PRKAA1/MYC/CDK6/KRAS/LAMC1/THBS1/COL1A1/ PPP2R5E/FOXO3) (Supplementary Figure 3A) , and the p53 signaling pathway including PERP/APAF1/CDK6/SESN2/THBS1/ SERPINE1 had the smallest P-value (Supplementary Figure 3B) , which showed the most significance. The 2 signaling pathways became the focus of our observation.
Screening of hub genes
In order to further find the hub genes of 128 FmRNAs in the network, STRING database (http://string-db.org), Cytoscape and its plugin (cytoHubba) were applied, and the results showed that 86 genes were related to each other ( Figure 6A ). According to cytoHubba plugin's MCC ranking, the top 10 hub genes were MYC (v-myc avian myelocytomatosis viral oncogene homolog), CTGF (connective tissue growth factor), TGFBR2 (TGF-beta receptor type-2), TGFBR1 (TGF-beta receptor type-1), SERPINE1 (plasminogen activator inhibitor 1), KRAS (Kirsten rat sarcoma viral oncogene homolog), ZEB1 (zinc finger E-box-binding homeobox 1), THBS 1 (thrombospondin-1), CDK6 (cyclin-dependent kinase 6), TNS1 (tensin-1) ( Figure 6B , Table 4 ). The expression of all the 10 genes was verified on the GEPIA, and it was found that MYC, TGFBR1, SERPINE1, and CDK6 showed statistically significant differences in expression ( Figure 7 ). In addition, we also found that highly expressed SERPINE1 had a poor OS and disease-free survival (DFS), and TGFBR1 expression increased along with the increase of clinical stages ( Figure 8 ) [18] . 
Discussion
Although the levels of diagnosis and treatment of GC is constantly improving, GC is still a high-risk disease, and a large part of its potential occurrence and development mechanism is still unclear. Prior to this, many studies on the pathogenesis of GC have been presented, but mainly focusing on genes encoding proteins. Since non-coding protein RNAs have appeared in everyone's field of vision and have been found to have specific regulatory functions, researchers have been investigating more and more non-coding RNAs, especially circRNAs. In this study, we discovered a few new circRNAs that target the regulation of downstream genes through sponge-adsorbed miRNAs. We also performed functional analysis of these target genes to understand the potential functions of these circRNAs.
In our study, we obtained a network of 3 circRNAs, 22 miRNAs, and 128 mRNAs using the GEO datasets. In addition, we found that on the CSCD website that hsa_circ_0009076 was composed of the 29 th and 30 th exons of the reverse transcript of the gene NRDC (location: 1p32.3, exon count: 35), hsa_circ_0028190 was composed of the 6 th -11 th exons of the reverse transcript of the gene ANAPC7 (location: 12q24.11, exon count: 13), and hsa_circ_0041732 was composed of the 8 th exons of the forward transcript of the gene FAM64A (location: 17p13.2, exon count: 16). The 3 circRNAs have not been reported previous in the literature. We named hsa_circ_0009076, hsa_circ_0028190, and hsa_circ_0041732 respectively as circNRDC, circANAPC7, and circFAM64A. In the future, more experiments will be needed to verify the expression of these circRNAs and their effects on the proliferation, apoptosis, invasion, and metastasis of GC cells.
In order to explore the indirect mechanism of circRNAs on GC, miRNAs and mRNAs of circRNAs downstream in the regulatory network were further analyzed. We validated the 22 differentially expressed miRNAs in TCGA database and found that the 8791 In future studies, more experiments are expected to verify this possible ceRNA mechanism in GC.
Conclusions
Although there are some studies on circRNA in GC, the number and methods of research are different. In this study, we constructed a circRNA-miRNA-mRNA regulatory network including 3 important circRNAs (hsa_circ_0009076, hsa_circ_0028190, and hsa_circ_0041732) through multiple GEO databases and TCGA database and performed functional enrichment analysis on these final target genes for understanding the potential functional mechanisms of circRNA. Of course, it is more important to combine basic experiments with clinical data to further explore the feasibility of these circRNAs, so as to provide new molecular marker of prediction, prognosis, and therapeutic targets for clinical patients.
